News
KSPHF
30.28
NaN%
--
Kissei Pharmaceutical Co (KSPHF) Receives a Buy from Nomura
TipRanks · 04/06 10:08
Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
TipRanks · 03/19 01:22
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
TipRanks · 02/27 07:10
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
TipRanks · 01/30 07:14
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
TipRanks · 01/30 07:13
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
TipRanks · 01/30 07:13
Kissei Pharmaceutical Co (KSPHF) Receives a Buy from Daiwa
TipRanks · 01/29 10:06
UBS Initiates a Hold Rating on Kissei Pharmaceutical Co (KSPHF)
TipRanks · 12/14/2025 13:55
Kissei Pharmaceutical Adjusts Dividend Payment Date
TipRanks · 12/01/2025 07:04
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
TipRanks · 11/05/2025 07:43
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
TipRanks · 11/04/2025 10:22
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
TipRanks · 11/04/2025 07:04
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
TipRanks · 10/27/2025 18:45
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
TipRanks · 10/27/2025 18:31
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
TipRanks · 10/27/2025 17:05
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
TipRanks · 10/27/2025 16:59
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
TipRanks · 10/27/2025 16:51
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
TipRanks · 10/23/2025 06:54
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
Barchart · 10/08/2025 02:08
More
Webull provides a variety of real-time KSPHF stock news. You can receive the latest news about Kissei Pharm through multiple platforms. This information may help you make smarter investment decisions.
About KSPHF
Kissei Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through four segments. The Pharmaceutical segment manufactures and sells prescription drugs, and also purchases and sells healthcare foods such as prescription drugs and foods for special medical purposes. The Goods Sales segment is engaged in the development, production and sale of noodles, the sale of various equipment, vehicles and fuel, as well as insurance agency business. The Information Services segment operates in three areas including system integration services, system resource services such as information-related equipment rental and network construction, and medical system development and sales. The Construction and Facility Maintenance segment provides comprehensive construction services ranging from building construction to the maintenance and management of equipment and facilities.